Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Preferred Stock Liabilities: 2018-2019

Historic Preferred Stock Liabilities for Revolution Medicines (RVMD) over the last 2 years, with Dec 2019 value amounting to $305.1 million.

  • Revolution Medicines' Preferred Stock Liabilities was N/A to $305.1 million in Q4 2019 from the same period last year, while for Dec 2019 it was $305.1 million, marking a year-over-year change of. This contributed to the annual value of $305.1 million for FY2019, which is 48.77% up from last year.
  • According to the latest figures from FY2019, Revolution Medicines' Preferred Stock Liabilities is $305.1 million, which was up 48.77% from $205.1 million recorded in FY2018.
  • In the past 5 years, Revolution Medicines' Preferred Stock Liabilities ranged from a high of $305.1 million in FY2019 and a low of $205.1 million during FY2018.
  • Its 2-year average for Preferred Stock Liabilities is $255.1 million, with a median of $255.1 million in 2018.
  • Data for Revolution Medicines' Preferred Stock Liabilities shows a peak YoY soared of 48.77% (in 2019) over the last 5 years.
  • Yearly analysis of 2 years shows Revolution Medicines' Preferred Stock Liabilities stood at $205.1 million in 2018, then surged by 48.77% to $305.1 million in 2019.